Iliac Stents Market Size & Share, By Type (Self-expandable, Balloon-Expandable, Covered Stents), Artery Lesions (Common Iliac Artery Lesions, Severe Calcified Lesions, Complete Obstructive Lesions), End-use (Hospital, ASCs), Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Iliac Stents Market size exceeded USD 926.9 Million in 2023 and is estimated to cross USD 1.47 Million by end of the year 2032, witnessing more than 5.2% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 926.9 Million
• CAGR (2024-2032): 5.2%
• Forecast Year Value (2032): USD 1.47 Million
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

1. Increasing prevalence of peripheral artery disease (PAD): PAD is a major driver of growth for the iliac stents market. As the global population ages and the rates of diabetes and obesity continue to rise, the prevalence of PAD is expected to increase, driving the demand for iliac stents.

2. Technological advancements in stent materials and designs: The continuous advancements in stent materials and designs are driving the growth of the iliac stents market. These advancements have resulted in the development of drug-eluting stents, bioresorbable stents, and improved stent deployment techniques, leading to higher success rates and lower rates of restenosis.

3. Growing demand for minimally invasive procedures: The increasing preference for minimally invasive procedures is a major growth driver for the iliac stents market. Minimally invasive procedures offer shorter hospital stays, faster recovery times, and reduced post-operative complications, leading to a higher demand for iliac stents.

4. Rising healthcare expenditure and infrastructure development: The increasing healthcare expenditure and infrastructure development in developing countries are creating significant growth opportunities for the iliac stents market. This growth is driven by the expansion of healthcare facilities, increased funding for medical research, and improved access to advanced medical technologies.

Report Scope

Report Coverage	Details
Segments Covered	Type, Artery Lesions, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Abbott Laboratories, Alvimedica, Becton, Dickinson and Company, Biotronik, Boston Scientific, B. Braun, Cook, Getinge AB, iVascular, Medtronic Plc

Industry Restraints:

1. Stringent regulatory requirements: The stringent regulatory requirements for the approval and commercialization of medical devices, including iliac stents, can act as a restraint on market growth. These requirements can lead to delays in product launches and increase the overall cost of development and commercialization.

2. Limited reimbursement policies: Limited reimbursement policies for iliac stent procedures in some regions can be a significant restraint on market growth. Patients may be deterred from undergoing stent placement due to high out-of-pocket costs, leading to lower demand for these devices.

3. Competition from alternative treatment options: The increasing availability and adoption of alternative treatment options, such as drug therapy and balloon angioplasty, can pose a challenge to the growth of the iliac stents market. Healthcare providers and patients may choose these alternative options over iliac stents, impacting market demand.

Regional Forecast:

North America:

The North American market for Iliac Stents is expected to witness significant growth due to the increasing prevalence of peripheral artery disease (PAD) and the growing geriatric population in the region. The United States and Canada are the key countries contributing to the growth of the market in North America. Furthermore, the presence of well-established healthcare infrastructure and the high adoption of advanced medical technologies are also driving the market growth in this region.

Asia Pacific:

In Asia Pacific, countries such as China, Japan, and South Korea are expected to witness substantial growth in the Iliac Stents market. This growth can be attributed to the rising awareness about peripheral artery disease and the increasing healthcare expenditure in these countries. Additionally, the rapidly expanding geriatric population and the growing demand for minimally invasive procedures are further boosting the market growth in the region.

Europe:

The Iliac Stents market in Europe is also poised for significant growth, with the United Kingdom, Germany, and France emerging as key markets in the region. The increasing prevalence of lifestyle-related diseases and the rising demand for advanced medical devices are driving the market growth in these countries. Moreover, the presence of well-established healthcare facilities and the growing investments in healthcare infrastructure are contributing to the growth of the Iliac Stents market in Europe.

Overall, the Iliac Stents market is expected to witness substantial growth across North America, Asia Pacific, and Europe, driven by factors such as the increasing prevalence of peripheral artery disease, the growing geriatric population, and the rising adoption of advanced medical technologies in these regions.

Segmentation Analysis:

In terms of segmentation, the global iliac stents market is analyzed on the basis of Type, Artery Lesions, End-Use.

Iliac Stents Market - Type

When it comes to segment analysis of the Iliac Stents Market, the type of stents is a key aspect to consider. Iliac stents are classified into two main types: bare-metal stents and drug-eluting stents. Bare-metal stents are made from a metal alloy and are designed to provide mechanical support to keep the iliac artery open. On the other hand, drug-eluting stents are coated with medication that helps to prevent restenosis, a condition where the artery becomes narrowed again after stenting. Each type of stent offers unique benefits and considerations for patients, and understanding the market dynamics for each type is essential for industry players.

Iliac Stents Market - Artery Lesions

Another important segment to analyze in the Iliac Stents Market is the various artery lesions that the stents are designed to address. Iliac artery lesions can range from simple stenosis (narrowing) to more complex lesions such as chronic total occlusions (complete blockage). Understanding the prevalence and characteristics of these artery lesions in the target patient population is crucial for developing effective marketing strategies and product positioning. Additionally, the ability of different stent types to effectively treat specific artery lesions can influence their market share and adoption rates.

Iliac Stents Market - End-Use

The end-use segment of the Iliac Stents Market refers to the different healthcare settings where iliac stents are utilized. This can include hospitals, ambulatory surgical centers, and specialty clinics. The end-use segment analysis is essential for understanding the distribution channels and purchasing behavior of healthcare providers. It also influences the demand for stents based on the procedural volumes in each setting and the patient population they serve. Furthermore, the preferences and requirements of different end-users can impact the development of new products and the marketing strategies employed by stent manufacturers.

Competitive Landscape:

The Iliac Stents Market is highly competitive with several major players vying for market share. The market is characterized by the presence of numerous global, regional, and local companies offering a wide range of products and services. These companies are constantly involved in research and development activities to introduce newer and advanced products to gain a competitive edge in the market. Some of the key factors driving competition in the market include product innovation, technological advancements, pricing strategies, and strategic collaborations. The top 10 companies operating in the Iliac Stent Market across the world are Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Cook Medical, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, C.R. Bard, Inc., W.L. Gore & Associates, Inc., and Translumina GmbH. These companies have a strong global presence and are known for their extensive product offerings and strong distribution networks. They are continuously engaged in strategic initiatives such as mergers and acquisitions, partnerships, and product launches to maintain their competitive position in the market.